J Biol Chem, Vol. 275, Issue 4, 2869-2876, January 28, 2000
A Protein Kinase from Neutrophils That Specifically
Recognizes Ser-3 in Cofilin*
Jian P.
Lian
§,
Peter G.
Marks¶,
Jay Y.
Wang
,
Douglas L.
Falls
, and
John A.
Badwey
§**
From the
Center for Experimental Therapeutics and
Reperfusion Injury, Brigham and Women's Hospital, Boston,
Massachusetts 02115, the ¶ Dana-Farber Cancer Institute, Boston,
Massachusetts 02115, the
Department of Biology, Emory
University, Atlanta, Georgia 30322, and the § Boston
Biomedical Research Institute, Boston, Massachusetts 02114
 |
ABSTRACT |
Cofilin promotes the depolymerization of actin
filaments, which is required for a variety of cellular responses such
as the formation of lamellipodia and chemotaxis. Phosphorylation of
cofilin on serine residue 3 is known to block these activities. We now report that neutrophils contain a protein kinase that selectively catalyzes the phosphorylation of cofilin on serine 3 (
70%) and a
nonspecific kinase that recognizes multiple sites in this protein. The
selective serine 3 cofilin kinase binds to a deoxyribonuclease I
affinity column, whereas the nonspecific cofilin kinase does not.
Deoxyribonuclease I forms a very tight complex with actin, and
deoxyribonuclease affinity columns have been utilized to identify a
variety of proteins that interact with the cytoskeleton. The serine 3 cofilin kinase did not react with antibodies to LIM kinase 1 or 2, which can catalyze the phosphorylation of cofilin in other cell types.
The activity of the serine 3 cofilin kinase was insensitive to a
variety of selective antagonists of protein kinases but was blocked by
staurosporine. This pattern of inhibition is similar to that observed
for the kinase that is active with cofilin in intact neutrophils. Thus,
neutrophils contain a protein kinase distinct from LIM kinase-1/2 that
selectively recognizes serine 3 in cofilin.
 |
INTRODUCTION |
Continuous polymerization and depolymerization of actin filaments
is required for various cell responses such as the formation of
lamellipodia, filopodia, and chemotaxis (e.g. Refs. 1-3). Cofilin is an essential actin-binding protein that promotes the depolymerization of older actin filaments (F-actin), thereby
facilitating the rate of filament turnover (e.g. Ref. 4; for
review, see Refs. 2 and 3). A recent study has shown that a simple
actin-based motility system (i.e. propulsion of the
intracellular pathogen Listeria monocytogenes) can be
reconstituted with only four purified components; actin, the Arp 2/3
complex (an actin-nucleating complex), capping protein, and
actin-depolymerizing factor
(ADF,1 a homologue of
cofilin) (Ref. 5; cf. Ref. 6). Cofilin can be
inactivated by phosphorylation on serine residue 3 (Ser-3) (7, 8) or by
binding phosphoinositides (9). The sequence surrounding Ser-3 in
cofilin (Ac-ASGVAVS-) is not recognized by several
Ser/Thr protein kinases of broad specificity (10).
Quantitatively, cofilin is one of the major phosphoproteins in
unstimulated neutrophils (11). Upon stimulation with the chemoattractant fMet-Leu-Phe (fMLP), neutrophils exhibit a rapid and
complete dephosphorylation of cofilin along with a massive translocation of this protein to the actin-rich, ruffling membranes (11-14). The actin cytoskeletal network plays a major role in the functional responses of neutrophils. For example, the disassembly rate
of pure F-actin without cofilin (0.044-1.14 µm/min) cannot account
for the rate of chemotaxis by cells (~30 µm/min)
(e.g. Refs. 4 and 15). Interestingly,
chemoattractant-stimulated neutrophils may establish discrete foci of
actin polymerization by activating the Arp 2/3 complex in a manner
similar to that observed for L. monocytogenes (16). A
considerable body of biochemical data suggest that the NADPH-oxidase
complex of neutrophils may be regulated by the actin cytoskeleton
(Refs. 17-20; for review, see Ref. 21). The NADPH-oxidase system
catalyzes the production of large quantities of
O2
/H2O2, which
are key components of the oxygen-dependent, antimicrobial arsenal of these cells (e.g. Ref. 21). Consistent with these biochemical studies, neutrophils stimulated under certain conditions exhibit oscillations in
O2
/H2O2
production that correlate with periodic extension and retraction of the
lamellipodia and polymerization/depolymerization of actin (22, 23). The
actin-rich, ruffling membranes of stimulated neutrophils are enriched
in products of the NADPH-oxidase complex (11, 21).
The actin cytoskeleton in neutrophils and other cell types is regulated
by members of the Rho family of small GTPases (e.g. Rac and
Cdc42) (e.g. Ref. 1). Recent reports have suggested that
activated (GTP-bound) Rac mediates actin reorganization, in part, by
stimulating LIM kinase 1 (LIMK1) (24, 25), which in turn catalyzes the
phosphorylation/inactivation of cofilin (24-26). However, this pattern
is not observed in neutrophils. In particular, neutrophils stimulated
with fMLP exhibit a pronounced activation of Rac (27, 28), which
coincides with a massive dephosphorylation of cofilin
(11-14).
In this paper, we describe a protein kinase from neutrophils that
selectively catalyzes the phosphorylation of cofilin on Ser-3. This
enzyme can be separated from a kinase(s) in these cells that recognizes
multiple sites in cofilin (by DNase-agarose affinity chromatography)
and appears to be distinct from LIMK. Some properties of this
Ser-3 cofilin kinase
(S3ck) are reported.
 |
EXPERIMENTAL PROCEDURES |
Materials
Affi-Gel 10 (N-hydroxysuccinimide active
ester-agarose) was purchased from Bio-Rad. 1,4-Phenylene
diisothiocyanate (DITC), cyanogen bromide (CNBr), myelin basic protein
(MBP), and CAPS were obtained from Sigma. Phenyl isothiocyanate (PITC)
was a product of Pierce. DNase I, HA1004, H-7, ML-7, KN-62, and
staurosporine were purchased from Calbiochem. Immobilon-P transfer
membranes (0.45 µm) were obtained from Millipore Corp. A goat
polyclonal antibody to LIMK-2 (LIMK-2 (C-19) Ab) was obtained from
Santa Cruz Biotechnology Co., Santa Cruz, CA. Sources of all other
materials are described elsewhere (29-31).
Methods
Preparation of Neutrophils and Cellular Fractions--
Guinea
pig peritoneal neutrophils were prepared as described previously (32).
These preparations contained >90% neutrophils with viabilities always
>90%.
Cells were suspended at a concentration of 2 × 108/ml
in freshly prepared, ice-cold extraction buffer (20 mM
Hepes (pH 7.5), 0.40 mM EGTA, 0.40 mM EDTA, 10 mM NaF, 0.40 mM NAVO4, 0.08 mM PMSF, 10 µg/ml leupeptin, and 10 µg/ml aprotinin)
and disrupted by freeze-thawing three times in a mixture of dry ice and
ethanol. The lysate was centrifuged at 200,000 × g
(4 °C) for 30 min. The supernatant was saved, and the pellet was
resuspended to the original volume in extraction buffer. Both fractions
were used immediately.
Preparation of Recombinant Cofilin--
A full-length cDNA
clone for human non-muscle cofilin was constitutively expressed in
bacteria using the plasmid vector pMW172. For large scale purification,
the bacterial pellet was resuspended in 20 mM Tris, 1 mM EGTA, pH 8.0 (purification buffer), sonicated and
centrifuged at 10,000 × g for 20 min. The supernatant
was applied to a DE52 column equilibrated with purification buffer. After washing with purification buffer, cofilin was eluted with 50 mM NaCl in purification buffer (pH adjusted to 8.0). All
steps were performed at 4 °C. Recombinant cofilin purified in this
manner was greater than 95% pure, as judged by SDS-PAGE analysis.
Typical yields of cofilin from 1 liter of bacteria were between 25 and 50 mg. The protein as eluted from the column was divided into small
aliquots and stored at 4 °C for periods of up to 1 month. Cofilin
stored in this manner for periods greater than 1 month exhibited
substantially less activity than freshly prepared cofilin when utilized
as a substrate for S3ck.
DNase I Affinity Chromatography for Cofilin Kinase--
DNase I
was covalently linked to Affi-Gel 10 according to the manufacturer's
instructions. After coupling, the gel was washed with 50 mM
Tris (pH 8.0) to eliminate unreacted N-hydroxysuccinimide esters. The beads were then washed with extraction buffer containing 0.40 M NaCl, followed by extraction buffer alone. The
resulting DNase-agarose beads (1.0 ml of swollen beads) were mixed with 3.0 ml of the soluble fraction of neutrophils in a rotating shaker for
30 min at 4 °C. The beads were then packed into a small column and
extensively washed with extraction buffer (~50 ml), followed by
extraction buffer containing 0.40 M NaCl (~10 ml). The
DNase 1-agarose beads containing the bound proteins were resuspended (1:1) in extraction buffer, and 20 µl of swollen beads were employed in the kinase assays.
Cofilin Kinase Assay--
Cofilin kinase activity was measured
as the transfer of 32Pi from
[
-32P]ATP into recombinant cofilin. In addition to the
bound kinase or neutrophil fractions, the final assay mixture (0.10 ml)
contained recombinant cofilin (7.5 µM), 20 mM
Hepes (pH 7.2), 10.0 mM MgCl2, 20 µM [
-32P]ATP (10 µCi), 0.10 mM EGTA, 2.0 mM p-nitrophenyl
phosphate, 2.0 mM NaF, and 20 µM
NaVO4. Assays were run for 20 min at 37 °C. The reaction
mixtures were then mixed with 12.5 µl of 5× sample buffer, immersed
in a boiling water bath for 3.0 min, and subjected to SDS-PAGE in
15.0% (w/v) polyacrylamide slab gels (0.075 × 12 × 14 cm).
The buffer system of Laemmli was employed (33). The final concentration
of sample buffer after mixing was 1.0% (w/v) SDS, 62.5 mM
Tris (pH 6.8), 5.0 mM EDTA, 10.0% (v/v) glycerol, 5.0%
(v/v) 2-mercaptoethanol, and 0.002% (w/v) bromphenol blue. 32P-Labeled cofilin was visualized by autoradiography. In a
number of experiments, the 32P-labeled cofilin band was
excised from the gel after staining with Coomassie Blue and the
radioactivity quantified by scintillation counting. The stoichiometry
of phosphorylation was calculated from the amount of radioactivity
incorporated into cofilin, the specific activity of the
[
-32P]ATP utilized, and the percentage of
radioactivity in Ser-3 as determined by Edman degradation (see below).
Activity was linear with regard to reaction time and protein
concentration in the range employed in these studies.
Manual Edman Degradation Technique for Sequencing and Identifying
Phosphorylated Amino Acids--
Cofilin was phosphorylated in
vitro and subjected to SDS-PAGE as described above.
32P-Labeled cofilin was transferred to an
Immobilin-P-membrane as described in Ref. 29, except the transfer
buffer consisted of 10.0 mM CAPS, 10.0 mM
mercaptoethanol, and 15% (v/v) methanol. The 32P-labeled
cofilin was "fixed" to these membranes with DITC (34) and subjected
to manual Edman degradation with PITC as described in Ref. 35. The
amount of 32P released in each cycle was determined by
liquid scintillation counting.
CNBr Digestion of Cofilin--
32P-Labeled cofilin
was separated on a 15% SDS-acrylamide "low cross-linked" gel
(100:1 (w/v) acrylamide/bisacrylamide). After separation, the cofilin
band was cut from the gel and subjected to CNBr digestion as described
in Ref. 36. The resulting peptides were separated on a 16.5%
Tricine/SDS-polyacrylamide gel (37) and stained with Ponceau Red.
Phosphopeptides were visualized by autoradiography. Peptides were
identified by sequencing the first 7-8 N-terminal amino acids on an
automated gas phase protein sequenator (Applied Biosystems). Mass
spectrometry of the peptides was performed on a Perspective Biosystems
Elite MALDI-TOF mass spectrometer.
Immunoprecipitation of LIM Kinase-1 and Immunoblotting--
An
immunoprecipitating antibody to LIMK1 was produced in rabbits to the
synthetic peptide
-acetyl-KETYRRGESSLPAHPEVPD and purified by
affinity chromatography as described in Ref. 38. Procedures for
immunoprecipitating LIMK1 from neutrophil lysates with the LIMK1 Ab (15 µg of Ab/200 µl of lysate) and for assaying the activity of the
precipitated kinase using recombinant cofilin as the substrate were
identical to methods previously utilized for the p21-activated kinases
(30, 39). Western blotting for LIMK1 was performed as described in Ref.
31. The primary Ab (~1.5 mg/ml) was diluted 1:2,000, and antigen was
visualized with a luminol-enhanced chemiluminescence detection system
(Pierce) followed by autoradiography for 10-30 s (40).
Analysis of Data--
Unless otherwise noted, all of the
autoradiographic observations were confirmed in at least three separate
experiments performed on different preparations of enzyme. The number
of observations (n) indicates the number of different
preparations of enzyme tested.
 |
RESULTS |
Protein Kinases in Neutrophils That Catalyze Phosphorylation of
Cofilin--
Recombinant cofilin and [
-32P]ATP served
as substrates to search for protein kinases in neutrophils that were
capable of catalyzing the phosphorylation of cofilin. The
phosphorylated proteins were separated by SDS-PAGE and examined by
autoradiography. Both the 200,000 × g soluble and the
particulate fractions from neutrophils contained kinases that were
active with cofilin (Fig. 1A).
The 32P-labeled cofilin band frequently appeared as a
doublet (e.g. Fig. 3B).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 1.
Protein kinases in neutrophils that catalyze
phosphorylation of cofilin. Panel A, autoradiograms
demonstrate the presence of protein kinases in the soluble and
particulate fractions of neutrophils that catalyze phosphorylation of
recombinant cofilin (7.5 µM). Reactions were run for 20 min at 37 °C, and phosphorylated (32P-labeled) cofilin
was separated by SDS-PAGE and monitored by autoradiography as described
under "Methods." The autoradiograms shown are for: soluble fraction
(a), soluble fraction plus cofilin (b),
particulate fraction (c), and particulate fraction plus
cofilin (d). The amounts of 32P in the
32P-labeled cofilin bands in lanes b and
d were approximately 40,000 and 120,000 cpm, respectively.
The position of cofilin is indicated by a solid arrow.
Panels B and C compare the release by manual
Edman degradation of 32P-labeled amino acids from the
phosphorylated cofilin bands shown in lanes b and
d of panel A. Cycle 2 of the Edman degradation
method releases serine 3 from recombinant cofilin because the initial
methionine residue (amino acid 1) was removed during the expression of
cofilin in bacteria. Data represent mean values ± S.D. from three
separate experiments.
|
|
To determine if the kinases in these cellular fractions recognized
Ser-3 in cofilin, the 32P-labeled cofilin bands were
transferred to Immobilon-P-membranes, fixed to the membranes with DITC
(34), and subjected to manual Edman degradation with PITC (35) (Fig.
1B). The amounts of 32P released in cycle-2 from
cofilin phosphorylated in vitro with the soluble and
particulate fractions were 32 ± 5.0% and 2.0 ± 0.50%
(S.D., n = 3), respectively. Cycle 2 releases Ser-3
from recombinant cofilin because the initial methionine residue (amino acid 1) was removed during the expression of this protein in bacteria. Thus, the soluble fraction of neutrophils contains a protein kinase that catalyzes the phosphorylation of cofilin on Ser-3.
Additional information on the sites in cofilin that undergo
phosphorylation in vitro was obtained by digesting the
32P-labeled cofilin bands with CNBr and subjecting the
resulting peptides to one-dimensional phosphopeptide mapping (Fig.
2A). The first 7-8 N-terminal
amino acids of these peptides were sequenced on an automated gas phase
protein sequenator (Fig. 2A, sequenced amino acids provided
on the right). All of the identified amino acids could be
aligned completely with the predicted sequence of human non-muscle
cofilin (41) and were preceded by methionine in accordance with the
known cleavage site for CNBr. Peptides p1, p2, and p3 exhibited
substantial amounts of 32P (Fig. 2A). Peptide p3
contained the N-terminal sequence of recombinant cofilin and exhibited
a mass of ~8,200 on mass spectrometry. The mass of p3 indicated that
this peptide was a partial hydrolysis product that consisted of amino
acid residues 2-74. We were unable to isolate a peptide consisting of
residues 2-18 in our system. Peptide p3 generated from cofilin
phosphorylated in vitro with the soluble fraction contained
substantially more 32P than peptide p3 from cofilin
phosphorylated with the membrane fraction (Fig. 2A, compare
p3 in lanes b and c). Peptide p2
contained substantial amounts of 32P in Ser-24 (Fig.
2B). Peptide p1 consisted of residues 116-166 and was also
phosphorylated. Thus, neutrophils contain kinases that can catalyze the
phosphorylation of cofilin on a variety of sites in
vitro.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 2.
One-dimensional phosphopeptide mapping of
32P-labeled recombinant cofilin phosphorylated in
vitro with kinases from neutrophils. Panel A,
recombinant cofilin was phosphorylated in vitro with protein
kinases present in the soluble (lanes a and b)
and particulate fractions (lane c) from neutrophils. The
cofilin bands were excised from the gel and digested with CNBr. The
peptides generated were separated by Tricine/SDS-PAGE and subjected to
autoradiography. The autoradiograms shown are for: intact cofilin
labeled with the soluble fraction (a), cofilin labeled with
the soluble fraction and digested with CNBr (b), and cofilin
labeled with the membrane fraction and digested with CNBr
(c). The first 7-8 N-terminal amino acids of some of these
peptides were identified on a gas phase protein sequenator (sequences
are provided on the right). The numbers in
parentheses refer only to the identified amino acids, not to
the entire sequence of the separated peptide. Intact cofilin is
designated by an arrow, and certain peptides resulting from
the digestion of cofilin are labeled p1, p1.5,
p2, and p3 (right margin).
Panels B and C show the release by manual Edman
degradation of 32P-labeled amino acids from peptides p3 and
p2 of lane b in panel A. Data represent mean
values ± S.D. of three separate experiments.
|
|
Isolation of a Protein Kinase from Neutrophils That Recognizes
Ser-3 in Cofilin--
Actin forms a stable complex with cofilin
(e.g. Ref. 42). Since high concentrations of actin are
present in the soluble fraction of neutrophils (e.g. Fig.
3A, lane c), we
were concerned that this association might interfere with the ability
of recombinant cofilin to serve as a substrate. DNase binds actin with
very high affinity (e.g. Ref. 43). A DNase affinity column
was therefore utilized to remove actin from the soluble fraction with
excellent results (Fig. 3A). Interestingly, this affinity
column also bound a protein kinase(s) that was highly selective for
Ser-3 in cofilin (referred to as Ser-3
cofilin kinase or S3ck) (Fig. 3,
B-D).

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 3.
Binding of a specific cofilin kinase to a
DNase-affinity column. Panel A, Coomassie Blue staining
pattern for: recombinant cofilin (a), purified actin
(b), 200,000 × g soluble fraction from
neutrophils (c), proteins that did not bind to DNase-agarose
beads (d), and proteins bound to the DNase-agarose beads
(e). The soluble fraction of neutrophils was incubated with
DNase-agarose beads for 30 min after which the bound and unbound
fractions were separated in a microcentrifuge. The positions of cofilin
and actin in the gel are designated by a broken arrow(s) and
solid arrow, respectively. Proteins designated by the
open arrowhead, closed arrowhead, and an
asterisk were identified by N-terminal sequencing and found
to be -tubulin, glyceraldehyde-3-phosphate dehydrogenase, and DNase,
respectively. Panel B, cofilin kinases in the different
fractions described above were assayed by monitoring
32P-labeled cofilin as described under "Methods." The
autoradiograms shown are for the: soluble fraction not incubated with
DNase-agarose (c), unbound fraction (d;
i.e. proteins that did not bind to DNase-agarose), bound
fraction (e), and bound proteins after washing with 0.40 M NaCl (f). Lane g is a control that
shows the labeling pattern of proteins bound to agarose beads that do
not contain covalently linked DNase. Phosphorylated cofilin frequently
appeared as a doublet (broken arrows). Panel C
shows the lower portion of the same autoradiogram presented in
panel B but developed for a shorter period of time. The
individual 32P-labeled cofilin bands are designated
I-VI. Panel D summarizes the percentage of
32P in Ser-3 for each of the phosphorylated cofilin bands
in panel C that are labeled I-VI. The amount of
32P in Ser-3 was determined by manual Edman degradation as
described under "Methods." Percentage of 32P in Ser-3
is defined as the amount of radioactivity released in the second cycle
of Edman degradation divided by the sum of radioactivity released and
the amount of radioactivity that remained bound on the Immobilon-P
membrane for that particular band.
|
|
As noted above, cofilin phosphorylated in vitro with the
soluble fraction frequently appeared as a double band after SDS-PAGE (Fig. 3, B and C; lane c, broken
arrows). The amounts of 32P in Ser-3 of the upper and lower
cofilin bands in lane c were determined by manual Edman
degradation and found to be ~5% and 58%, respectively. A pronounced
diminution of the lower phosphorylated cofilin band was observed when
the proteins not bound to the DNase-agarose beads were tested for
kinase activity (Fig. 3C, lane d). In contrast, the protein kinase that bound to the DNase-agarose beads catalyzed the
phosphorylation/generation of only the lower, 32P-labeled
cofilin band (Fig. 3B, lane e). The kinase bound
to the beads (S3ck) was not removed by washing the column with 0.40 M NaCl (Fig. 3B, lane f). After
washing with 0.40 M NaCl, the kinase which remained bound
to the beads was highly selective for Ser-3 in cofilin with 78% of the
32P present in this residue after catalysis (Fig.
3D). This value for six different experiments was 74 ± 5% (n = 6, S.D.). Affi-Gel beads without covalently
linked DNase did not contain this kinase activity (Fig. 3B,
lane g). The stoichiometry of phosphate incorporation into
Ser-3 of cofilin (7.5 µM) with S3ck bound to the
DNase-agarose beads (~0.8 × 107 cell eq) under the
standard assay conditions (37 °C, 20 min) was calculated to be about
0.4 mol of phosphate incorporated/mol of cofilin (0.42 ± 0.12;
S.D., n = 4).
The specificity of the kinase bound to the DNase-affinity column was
further investigated by digesting the product of this reaction with
CNBr and examining the resulting phosphopeptides (Fig.
4). The predominant
32P-labeled peptide was p3 (Fig. 4, lane b), and
the amounts of radioactivity in peptides p2 and p1 were markedly
reduced when compared with those generated from cofilin phosphorylated
in vitro with the kinases present in the soluble fraction.
These data are in agreement with those obtained by the Edman
degradation method and further establish that the bound activity
selectively recognizes Ser-3 in cofilin (see "Discussion"). Since
the bound S3ck has not been purified to homogeneity, we do not know if
this activity represents a single enzyme or a group of enzymes.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 4.
Phosphopeptide analysis of cofilin
phosphorylated in vitro with the kinase bound to the
DNase-affinity column. Cofilin was phosphorylated in
vitro with the kinase bound to the DNase affinity column, excised
from the gel, and digested with CNBr. Autoradiograms shown are for:
intact cofilin phosphorylated with the kinase bound to the affinity
column (a), cofilin phosphorylated with the kinase bound to
the affinity column and digested with CNBr (b), and cofilin
phosphorylated with the kinases present in the 200,000 × g soluble fraction and digested with CNBr (c).
Intact cofilin is designated by the upper arrow,
and certain phosphopeptides resulting from the digestion of cofilin are
labeled p1, p2, and p3
(right margin), as in Fig. 2.
|
|
Interactions of recombinant cofilin with the DNase affinity column were
investigated (Fig. 5). Significant
quantities of unphosphorylated cofilin were bound to the DNase-agarose
beads under the conditions of the kinase assay (Fig. 5A).
However, after phosphorylation, 32P-labeled cofilin did not
associate with the beads (Fig. 5B). Phosphorylation of
cofilin on Ser-3 is known to result in the dissociation of
cofilin-G-actin complexes (10, 44).

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 5.
Interactions of cofilin with the kinase bound
to the DNase affinity column. Panels A and B,
phosphorylation of cofilin was catalyzed by the DNase-agarose bound
kinase for 20 min, and the reaction mixture was subjected to
centrifugation in a microcentrifuge for 20 s at maximum speed to
separate the soluble fraction from the DNase-agarose beads. Panel
A shows the Coomassie Blue staining pattern for proteins bound to
the DNase-agarose beads (a) and the soluble fraction
(b). Panel B shows the autoradiogram for
32P-labeled cofilin in these fractions. Panels C
and D, DNase-agarose beads containing the bound kinase were
incubated with cofilin (7.0 µM) in the normal reaction
mixture but without ATP for 30 min at 37 °C and then separated from
the soluble fraction as described above. The beads were washed three
times in the kinase buffer without ATP. The abilities of the resulting
fractions to catalyze the phosphorylation of cofilin were then assayed
for 20 min at 37 °C. Panel C shows the autoradiograms for
32P-labeled cofilin that resulted from the following
conditions: a, DNase-agarose beads supplemented with
additional cofilin (7.0 µM); b, soluble
fraction supplemented with additional cofilin (7.0 µM);
c, DNase-agarose beads without additional cofilin;
d, soluble fraction without additional cofilin;
e, control reaction with 14.0 µM cofilin added
to the kinase bound to DNase-agarose beads. Sample (e) was
not subjected to pretreatment with cofilin or centrifugation.
Panel D shows the Coomassie Blue staining pattern for the
proteins present in the fractions described in panel C.
Conditions for the in vitro phosphorylation of cofilin and
SDS-PAGE are described under "Methods." The positions of cofilin
and actin are designated by a broken arrow and solid
arrow, respectively.
|
|
If the binding of S3ck to the DNase-agarose beads was due to the kinase
forming a complex with endogenous cofilin associated with the beads, it
was possible that S3ck could be released from the beads by exogenous
cofilin. This possibility was examined by incubating the bound kinase
with exogenous cofilin (7.0 µM) for 30 min in the absence
of ATP and then separating the beads from the supernatant/soluble
fraction. Assaying the resulting fractions either with or without
additional cofilin demonstrated that the majority of the kinase
activity remained associated with the beads (Fig. 5C). These
data strongly suggest that the binding of S3ck to the DNase affinity
column involves more than the formation of a simple enzyme-substrate complex.
Comparison of LIMK1 in Neutrophils to S3ck--
As noted above,
recent studies have reported that LIMK1 can catalyze the
phosphorylation of cofilin on Ser-3 (24-26). LIMK1 is a cytosolic
protein, has a predicted molecular mass of 74 kDa, and catalyzes the
phosphorylation of MBP in vitro (45). An affinity-purified, polyclonal anti-LIMK1 Ab generated to a peptide corresponding to the
C-terminal region of rat LIMK1 (38) was utilized to probe for this
kinase in various fractions from neutrophils (Fig.
6). Two prominent immunoreactive bands
with molecular masses of ~83 and 74 kDa were observed when the
200,000 × g soluble fraction was examined by Western
blotting along with several other minor bands (Fig. 6B,
lane a). The 83-kDa band ran at the same position as LIMK1
in a lysate from rat brain during Western blotting, and both the 83- and 74-kDa bands were completely blocked by the immunizing peptide
(data not shown). Interestingly, none of these bands were observed when
the proteins bound to the DNase-affinity column were analyzed (Fig.
6B, lane c), even though this fraction was highly
enriched in S3ck (Fig. 6A, lane c). The 83- and
74-kDa proteins remained soluble and did not bind to the DNase-agarose beads (Fig. 6B, lane b). No bands were observed
in any of the fractions from neutrophils when a commercial Ab to LIMK-2
(LIMK-2 (C-19) Ab) was utilized in these experiments (data not
shown).

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 6.
Comparison of the distribution of LIMK1 in
neutrophils with the distribution of S3ck. Panel A,
autoradiogram demonstrates the ability of protein kinases from
neutrophils to catalyze the phosphorylation of cofilin. The source of
the protein kinases were: 200,000 × g soluble fraction
not incubated with DNase-agarose (a), proteins that did not
bind to DNase-agarose (b), and proteins bound to the
DNase-agarose beads (c). 69% of the 32P in
cofilin from lane c was in Ser-3. The position of a 68-kDa
protein that underwent phosphorylation or autophosphorylation during
the kinase reaction is designated by a solid
arrow. 32P-Labeled cofilin is designated by
broken arrows. Panel B, Western blot compares the
presence of LIMK1 in the fractions utilized in panel A. The
positions of the 83- and 74-kDa proteins that reacted with the LIMK1 Ab
are designated by a closed arrowhead and an open
arrowhead, respectively.
|
|
When lysates of neutrophils (2 × 108 cell eq/ml) were
treated with the LIMK1 Ab (15 µg of Ab/200 µl of lysate for
3.0 h) and the resulting immune complexes subjected to SDS-PAGE
and Western blotting with the same Ab, immunoreactive bands of 83 and
74 kDa were observed (data not shown). When the LIMK1 immune complexes derived from neutrophils were tested in protein kinase assays, substantial activity was observed when MBP was the substrate (Fig. 7, lane e). Considerably less
activity was observed with recombinant cofilin (Fig. 7, lane
c). In three separate experiments analyzing the activity of the
kinase(s) immunoprecipitated from neutrophils with the LIMK1 Ab, the
amounts of radioactivity in the phosphorylated MBP and cofilin bands
were 6,008 versus 750 cpm, 9,030 versus 514 cpm,
and not detectable versus 1,763 cpm, respectively. When the
32P-labeled cofilin bands from these experiments were
subjected to manual Edman degradation, the amounts of 32P
in Ser-3 were 8%, 16%, and 18%. In contrast, under the same assay
conditions, the corresponding values for the reaction catalyzed by the
S3ck bound to DNase-agarose (i.e. Fig. 7, lane g)
were 77%, 71%, and 78%, respectively. Cofilin phosphorylated with
the the immunoprecipitated kinase(s) (Fig. 7, lane c) ran at
a slightly slower rate during SDS-PAGE than that phosphorylated with
S3ck (Fig. 7, lane g), which indicates that the
immunoprecipitated enzyme(s) catalyzed the phosphorylation of cofilin
in a manner similar to the kinase(s) that did not bind to the
DNase-agarose beads (see Fig. 3C, lane d). These
data strongly suggest that the S3ck of neutrophils is distinct from
LIMK-1/2.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 7.
Phosphorylation of cofilin with
immunoprecipitates obtained with the LIM kinase 1 antibody and S3ck
from neutrophils. Autoradiogram compares the abilities of protein
kinases from neutrophils to catalyze the phosphorylation of cofilin.
The conditions compared are: 200,000 × g soluble
fraction without added substrate (a), 200,000 × g soluble fractions plus cofilin (7.5 µM)
(b), immunoprecipitated LIMK1 plus cofilin (7.5 µM) (c), immunoprecipitated LIMK1 without
substrate (d), immunoprecipitated LIMK1 plus myelin basic
protein (7.0 µM) (e), DNase-bound kinase
without substrate (f), DNase-bound kinase plus cofilin (7.5 µM) (g), and DNase-bound kinase plus myelin
basic protein (7.0 µM) (h). Conditions for
assaying protein kinases and immunoprecipitating LIMK1 from neutrophil
lysates are described under "Methods." 32P-Labeled
cofilin is designated by a broken arrow.
|
|
Properties of the Ser-3 Cofilin Kinase (S3ck) from
Neutrophils--
The protein kinase bound to the DNase-agarose beads
displayed hyperbolic, Michaelis-Menten saturation kinetics for cofilin (Fig. 8A) (i.e.
Hill coefficient of 1.0; data not shown), and the double-reciprocal
plot revealed a Km of approximately 4.0 µM for cofilin (4.3 ± 0.4 µM, S.D.,
n = 3) (Fig. 8B). The Vmax was estimated to be 31 ± 9 pmol of
P/min/107 cell eq (S.D., n = 4).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 8.
Kinetics of S3ck from neutrophils.
Panel A, the rate of cofilin phosphorylation catalyzed by
the kinase bound to the DNase-agarose beads was measured at several
different concentrations of cofilin. The kinase reaction was run for 20 min, the resulting 32P-labeled cofilin bands were excised
from the gels, and the total radioactivity quantified by liquid
scintillation counting as described under "Methods." The
inset shows the autoradiograph for 32P-labeled
cofilin for the following concentrations of substrate: a,
0.30 µM; b, 0.60 µM;
c, 0.90 µM; d, 1.2 µM; e, 2.4 µM; f, 4.8 µM; g, 9.6 µM; h,
14.4 µM; and i, 19.2 µM.
Panel B, Lineweaver-Burke (double-reciprocal) plot for the
data from panel A.
|
|
A partially purified protein kinase from plants can catalyze the
phosphorylation of maize cofilin on Ser-6, which is equivalent to Ser-3
in vertebrate cofilin (46). This kinase from plants was stimulated by
Ca2+ (0.40 mM) (46). We therefore investigated
the effects of Ca2+ on the S3ck from neutrophils. Addition
of CaCl2 (0.40 mM) or EGTA (0.50 mM) to the assay mixture did not affect the activity of the
S3ck bound to the DNase-agarose beads (n = 2) (data not shown).
We have previously reported that cofilin kinase in intact neutrophils
was not affected by the antagonists H-7, HA1004, ML-7, or KN-62 but was
inhibited by staurosporine (11). Staurosporine is a nonspecific
antagonist of protein kinases (47). Compounds H-7, HA1004, ML-7, and
KN-62 are selective antagonists of protein kinase C, the cyclic
nucleotide-dependent kinases, myosin light chain kinase,
and certain Ca2+/calmodulin dependent kinases, respectively
(48-50). The effects of these antagonists on the activity of the bound
S3ck are presented in Fig. 9. Only
staurosporine (0.20 µM) was found to be an effective inhibitor. Thus, the sensitivity of the isolated S3ck to various antagonists in vitro paralleled that observed for the
protein kinase that recognizes cofilin in vivo. We also
observed that isolated protein kinase C (mixture of
,
, and
isoforms), myosin light chain kinase, and p21-activated protein kinase
(Pak,
and
isoforms) did not catalyze the phosphorylation of
cofilin on Ser-3 in vitro (data not shown) (cf.
Ref. 10).

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 9.
Effects of various kinase inhibitors on the
Ser-3 cofilin kinase from neutrophils. Panel A,
autoradiogram demonstrates the effects of selective inhibitors of
protein kinases on the cofilin kinase bound to the DNase-agarose beads.
The kinase was incubated with the inhibitor for 5 min in the standard
reaction mixture before initiating the reaction with 10 µM [ -32P]ATP (10 µCi). The
autoradiograph shown is for the complete reaction mixture with the
following modifications or additions: a, without cofilin;
b, positive control (i.e. complete reaction
mixture); c, 10 µM HA1004; d, 10 µM H-7; e, 10 µM ML-7;
f, 10 µM KN-62; g, 0.20 µM staurosporine; and h, a second positive
control. Panel B, histogram summarizes data from several
different experiments examining the effects of various antagonists on
the cofilin kinase bound to the DNase-agarose beads. Kinase activity
was measured as described under "Methods," the
32P-labeled cofilin bands were excised from the gels, and
the total radioactivity quantified by liquid scintillation counting.
Data represent mean values ± S.D. for three to five separate
experiments that employed different preparations of enzyme.
|
|
Finally, we could not detect significant activity for S3ck after
fractionation of the proteins in the 200,000 × g
soluble fraction by HPLC on a Shodex KW-803 column, which separates
proteins on the basis of size. The column was run at a flow rate of
0.50 ml/min with the "extraction buffer" containing 100 mM KCl or NaCl used as the elution buffer. In contrast, a
nonspecific cofilin kinase that was not active at Ser-3 was readily
detectable in the 40-50-kDa region of the chromatograms
(n = 3; data not shown). We are currently surveying a
variety of tissues and techniques to enrich S3ck for sequencing experiments.
 |
DISCUSSION |
In this paper, we describe a protein kinase from neutrophils that
selectively (>70%) catalyzes the phosphorylation of cofilin on Ser-3.
As noted above, phosphorylation of cofilin on this residue blocks its
ability to promote disassembly of actin-filaments (7, 8, 10). The S3ck
we describe appears to be distinct from LIMK1 which recognizes cofilin
in other cell types (24-26). The significance of these observations
and properties of the enzyme are discussed below.
We have previously presented pharmacological evidence that cofilin is
regulated by a continual cycle of phosphorylation and dephosphorylation
in unstimulated neutrophils and that the phosphatase undergoes
activation during cell stimulation (11). Activation of the cofilin
phosphatase would account for the rapid dephosphorylation/activation of
cofilin that is observed in stimulated neutrophils (11-14). Activated
cofilin would promote the rapid changes in actin polymerization and
depolymerization that are crucial for lamellipodia/pseudopodia formation, phagocytosis, and chemotaxis (11-14). Cofilin kinase in
unstimulated neutrophils was constitutively active, insensitive to H-7,
HA1004, ML-7, and KN-62 but inhibited by staurosporine (11). The
cofilin kinase we describe in this paper exhibits similar properties
(e.g. Figs. 1 and 9).
Recent studies have shown that LIMK1 can catalyze the phosphorylation
of cofilin (24-26). Transfection of LIMK1, but not inactive forms of
this enzyme, into certain cells promoted the phosphorylation of cofilin
(24, 25) along with the expected morphological changes (24-26).
Immunopurified recombinant LIMK1 catalyzed the phosphorylation of
(His)6-tagged cofilin and a GST-cofilin fusion protein but
was inactive against a S3A-cofilin mutant in which Ser-3 was replaced
by an alanine residue (24, 25). Interestingly, chick brain cofilin/ADF,
but not a GST fusion protein of Xenopus cofilin/ADF, was phosphorylated in vivo when injected into
Xenopus eggs (51). These data indicate that the GST chimeric
construct was not a substrate for the endogenous cofilin kinase in this system (51). Transfection studies with a variety of Rac mutants provided evidence that activated (GTP-bound) Rac stimulates the activity of LIMK1 and promoted phosphorylation of cofilin. Thus, it was
proposed that LIMK1 was a link between activated Rac and the actin
cytoskeleton (i.e. Rac-GTP
LIMK1
cofilin-P
actin filament dynamics) (24, 25).
The situation in neutrophils is clearly different from that described
above for transfected cells. While two immunoreactive bands for LIMK1
were observed in neutrophils, these bands were not present in fractions
enriched in S3ck activity (Fig. 6). Moreover, LIMK1
immunoprecipitated from lysates of neutrophils displayed relatively
little activity toward cofilin when compared with MBP as the substrate,
and the amounts of 32P found in Ser-3 of cofilin after
catalysis were only about 8-18% (Fig. 7). It is possible
that LIMK1 is specific for Ser-3 in cofilin but associates with
nonspecific cofilin kinase(s) in these immunoprecipitates that reduce
the overall percentage of radioactivity incorporated into Ser-3.
Nonspecific kinases that recognize multiple sites in cofilin are
present in neutrophils (Figs. 1 and 2). However, the S3ck that bound to
the DNase-agarose beads was highly selective/specific for Ser-3
(
70%) (see below) under the same assay conditions (Fig. 7). Thus, if
S3ck was in fact LIMK1, it would have to have lost both its ability to
associate with the nonspecific kinase(s) and to react with the LIMK1
antibody. It is not known if cofilin in neutrophils undergoes
phosphorylation on serine residues other than Ser-3 or if LIMK might
catalyze these reactions. However, if LIMK does catalyze the
phosphorylation of cofilin in these cells, it is not likely to be
stimulated by activated Rac. As noted above, Rac undergoes a pronounced
activation in stimulated neutrophils during the same time period
(e.g. Refs. 27 and 28) in which cofilin undergoes massive
dephosphorylation (11-14). Thus, the available data indicate that the
major S3ck in neutrophils is not likely to be LIMK1 and that activated
Rac does not promote net phosphorylation of cofilin in these cells.
As noted above, when 32P-labeled cofilin prepared with S3ck
was subjected to manual Edman degradation, about 70-80% of the
32P was released with Ser-3 (Fig. 3). In fact, the actual
amount of phosphorylation at this residue is likely to be even higher. The manual Edman degradation method works only on proteins/peptides in
which the N-terminal amino group is free/unmodified (35). However, the
reagent DITC, which is utilized to fix cofilin to the Immobilon-P
membrane for sequencing, reacts through free amino groups (34). Thus,
the S3ck of neutrophils is highly specific for Ser-3 and shows little
activity toward serine or threonine residues that reside in consensus
sequences recognized by a variety of other protein kinase
(e.g. Ser-24, Thr-25) (10, 52).
The DNase-agarose beads used to partially purify S3ck form a very tight
complex with monomeric actin, which in turn binds to a variety of
actin-binding proteins (e.g. Ref. 43). Binding of this
kinase to DNase-agarose beads is likely to involve (a) protein(s) other
than cofilin since free cofilin alone could not elute S3ck from the
beads (Fig. 5B). The possibility exists that the
phosphorylation of cofilin on Ser-3 may require proteins in addition to
S3ck that are also bound to the beads (cf. Ref. 53).
In summary, we have reported that neutrophils contain a constitutively
active protein kinase that selectively recognizes Ser-3 in cofilin and
that this enzyme appears to be distinct from LIMK1. The sensitivity of
this enzyme to a variety of kinase inhibitors in vitro
parallels that observed in vivo for the physiological enzyme. This kinase can now be utilized to generate the large quantities of substrate that are needed to characterize the phosphatase that catalyzes the dephosphorylation/activation of cofilin in stimulated neutrophils.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants DK 50015, AI 23323, K08 HL-03235, and GM 56337.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed: Center for Experimental
Therapeutics and Reperfusion Injury, Brigham and Women's Hospital,
Thorn Bldg., Rm. 703, 75 Francis St., Boston, MA 02115. Tel.:
617-278-0735; Fax: 617-278-6957; E-mail:
badwey@zeus.bwh.harvard.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
ADF, actin-depolymerizing factor;
fMLP, f-Met-Leu-Phe;
S3ck, Ser-3 cofilin kinase;
LIMK1, LIM kinase 1;
DITC, 1,4-phenylene diisothiocyanate;
PITC, phenyl
isothiocyanate;
CAPS, cyclohexylaminopropanesulfonic acid;
Ab, antibody;
H-7, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine;
HA1004, N-(2-guanidinoethyl)-5-isoquinolinesulfonamide;
ML-7, 1-(5-iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine
hydrochloride;
KN-62, 1-[N,O-bis(1,5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine;
GST, glutathione S-transferase;
MBP, myelin basic protein;
PAGE, polyacrylamide gel electrophoresis;
Tricine, N-tris(hydroxymethyl)methylglycine.
 |
REFERENCES |
| 1.
|
Hall, A.
(1998)
Science
279,
509-514[Abstract/Free Full Text]
|
| 2.
| Moon, A., and Drubin, D. G. (1995) Mol. Biol. Cell
(1995) 6, 1423-1431
|
| 3.
|
Theriot, J. A.
(1997)
J. Cell Biol.
136,
1165-1168[Free Full Text]
|
| 4.
|
Rosenblatt, J.,
Agnew, B. J.,
Abe, H.,
Bamburg, J. R.,
and Mitchison, T. J.
(1997)
J. Cell Biol.
136,
1323-1332[Abstract/Free Full Text]
|
| 5.
|
Loisel, T. P.,
Boujemaa, R.,
Pantaloni, D.,
and Carlier, M.-F.
(1999)
Nature
401,
613-616[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Machesky, L. M.,
and Cooper, J. A.
(1999)
Nature.
401,
542-543[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Agnew, B. J.,
Minamide, L. S.,
and Bamburg, J. R.
(1995)
J. Biol. Chem.
270,
17582-17587[Abstract/Free Full Text]
|
| 8.
|
Ressad, F.,
Didry, D.,
Egile, C.,
Pantaloni, D.,
and Carlier, M.-F.
(1999)
J. Biol. Chem.
274,
20970-20976[Abstract/Free Full Text]
|
| 9.
|
Yonezawa, N.,
Nishida, E.,
Iida, K.,
Yahara, I.,
and Sakai, H.
(1990)
J. Biol. Chem.
265,
8382-8386[Abstract/Free Full Text]
|
| 10.
|
Morgan, T. E.,
Lockerbie, R. O.,
Minamide, L. S.,
Browning, M. D.,
and Bamburg, J. R.
(1993)
J. Cell Biol.
122,
623-633[Abstract/Free Full Text]
|
| 11.
|
Heyworth, P. G.,
Robinson, J. M.,
Ding, J.,
Ellis, B. A.,
and Badwey, J. A.
(1997)
Histochem. Cell Biol.
108,
221-233[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Suzuki, K.,
Yamaguchi, T.,
Tanaka, T.,
Kawanishi, T.,
Nishimaki-Mogami, T.,
Yamamoto, K.,
Tsuji, T.,
Irimura, T.,
Hayakawa, T.,
and Takahashi, A.
(1995)
J. Biol. Chem.
270,
19551-19556[Abstract/Free Full Text]
|
| 13.
|
Okada, K.,
Takano-Ohmuro, H.,
Obinata, T.,
and Abe, H.
(1996)
Exp. Cell Res.
227,
116-122[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Djafarzadeh, S.,
and Niggli, V.
(1997)
Exp. Cell Res.
236,
427-435[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Zigmond, S. H.
(1993)
Cell Motil. Cytoskel.
25,
309-316[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Weiner, O. D.,
Servant, G.,
Welch, M. D.,
Mitchison, T. J.,
Sedat, J. W.,
and Bourne, H. R.
(1999)
Nat. Cell Biol.
1,
75-81[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Quinn, M. T.,
Parkos, C. A.,
and Jesaitis, A. J.
(1989)
Biochim. Biophys. Acta
987,
83-94[Medline]
[Order article via Infotrieve]
|
| 18.
|
Nauseef, W. M.,
Volpp, B. D.,
McCormick, S.,
Leidal, K. G.,
and Clark, R. A.
(1991)
J. Biol. Chem.
266,
5911-5917[Abstract/Free Full Text]
|
| 19.
|
El Benna, J.,
Ruedi, J. M.,
and Babior, B. M.
(1994)
J. Biol. Chem.
269,
6729-6734[Abstract/Free Full Text]
|
| 20.
|
Curnutte, J. T.,
Erickson, R. W.,
Ding, J.,
and Badwey, J. A.
(1994)
J. Biol. Chem.
269,
10813-10819[Abstract/Free Full Text]
|
| 21.
|
Robinson, J. M.,
and Badwey, J. A.
(1995)
Histochem. Cell Biol.
103,
163-180[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Wyman, M. P.,
Kernen, P.,
Deranleau, D. A.,
and Baggiolini, M.
(1989)
J. Biol. Chem.
264,
15829-15834[Abstract/Free Full Text]
|
| 23.
|
Wyman, M. P.,
Kernen, P.,
Bengtsson, T.,
Anderson, T.,
Baggiolini, M.,
and Deranleau, D. A.
(1990)
J. Biol. Chem.
265,
619-622[Abstract/Free Full Text]
|
| 24.
|
Arber, S.,
Barbayannis, F. A.,
Hanser, H.,
Schneider, C.,
Stanyon, C. H.,
Bernard, O.,
and Caroni, P.
(1998)
Nature
393,
805-809[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Yang, N.,
Higuchi, O.,
Ohashi, K.,
Nagata, K.,
Wada, A.,
Kangawa, K.,
Nishida, E.,
and Mizuno, K.
(1998)
Nature
393,
809-812[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Edwards, D. C.,
and Gill, G. N.
(1999)
J. Biol. Chem.
274,
11352-11361[Abstract/Free Full Text]
|
| 27.
|
Benard, V.,
Bohl, B. P.,
and Bokoch, G. M.
(1999)
J. Biol. Chem.
274,
13198-13204[Abstract/Free Full Text]
|
| 28.
|
Geijsen, N.,
van Delft, S.,
Raaijmakers, J. A. M.,
Lammers, J.-W., J.,
Collard, J. G.,
Koenderman, L.,
and Coffer, P. J.
(1999)
Blood
94,
1121-1130[Abstract/Free Full Text]
|
| 29.
|
Ding, J.,
and Badwey, J. A.
(1993)
J. Biol. Chem.
268,
5234-5240[Abstract/Free Full Text]
|
| 30.
|
Ding, J.,
Knaus, U. G.,
Bokoch, G. M.,
Lian, J. P.,
and Badwey, J. A
(1996)
J. Biol. Chem.
271,
24869-24873[Abstract/Free Full Text]
|
| 31.
|
Huang, R.,
Lian, J. P.,
Robinson, D.,
and Badwey, J. A.
(1998)
Mol. Cell. Biol.
18,
7130-7138[Abstract/Free Full Text]
|
| 32.
|
Badwey, J. A.,
and Karnovsky, M. L.
(1986)
Methods Enzymol.
132,
365-368[Medline]
[Order article via Infotrieve]
|
| 33.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Pappin, D. J. C.,
Coull, J. M.,
and Köster, H.
(1990)
Anal. Biochem.
187,
10-19[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Sullivan, S.,
and Wong, T. W.
(1991)
Anal. Biochem.
197,
65-68[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Kolbe, H. V. J.,
and Wohlrab, H.
(1985)
J. Biol. Chem.
260,
15899-15906[Abstract/Free Full Text]
|
| 37.
|
Schagger, H.,
and von Jagow, G.
(1987)
Anal. Biochem.
166,
368-379[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Wang, J. Y.,
Frenzel, K. E.,
Wen, D.,
and Falls, D. L.
(1998)
J. Biol. Chem.
273,
20525-20534[Abstract/Free Full Text]
|
| 39.
|
Lian, J. P.,
and Badwey, J. A.
(1997)
FEBS Lett.
404,
211-215[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Pierce Chemical Co.
(1996)
SuperSignal Substrate Western Blotting Kits No. 34081-34086
, Pierce Chemical Co., Rockford, IL
|
| 41.
|
Ogawa, K.,
Tashima, M.,
Yumoto, Y.,
Okuda, T.,
Sawada, H.,
Okamura, M.,
and Moruyama, Y.
(1991)
Nucleic Acids Res.
18,
7169
|
| 42.
|
Nishida, E.
(1985)
Biochemistry
24,
1160-1164[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Markey, F.,
Persson, T.,
and Lindberg, U.
(1981)
Cell
23,
145-153[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Moriyama, K.,
Iida, K.,
and Yaha, I.
(1996)
Genes Cell
1,
73-86[Abstract]
|
| 45.
|
Okano, I.,
Hiraoko, J.,
Otera, H.,
Nunoue, K.,
Ohashi, K.,
Iwashita, S.,
Hirai, M.,
and Mizuno, K.
(1995)
J. Biol. Chem.
270,
31321-31330[Abstract/Free Full Text]
|
| 46.
|
Smertenko, A. P.,
Jiang, C.-J.,
Simmons, N. J.,
Weeds, A. G.,
Davies, D. R.,
and Hussey, P. J.
(1998)
Plant J.
14,
187-193[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Tamaoki, T.,
Nomoto, H.,
Takahashi, I.,
Kato, Y.,
Morimoto, M.,
and Tomita, F.
(1986)
Biochem. Biophys. Res. Commun.
135,
397-402[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Hidaka, H.,
Inogaki, M.,
Kawamoto, S.,
and Sasaki, Y.
(1984)
Biochemistry
23,
5036-5041[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Saitoh, M.,
Ishikawa, T.,
Matsushima, S.,
Naka, M.,
and Hidaka, H.
(1987)
J. Biol. Chem.
262,
7796-7801[Abstract/Free Full Text]
|
| 50.
|
Tokumitsu, H.,
Chijuia, T.,
Hagiwara, M.,
Mizutani, A.,
Terasawa, M.,
and Hidaka, H.
(1990)
J. Biol. Chem.
265,
4315-4320[Abstract/Free Full Text]
|
| 51.
|
Abe, H.,
Obinatra, T.,
Minamide, L. S.,
and Bamburg, J. R.
(1996)
J. Cell Biol.
132,
871-885[Abstract/Free Full Text]
|
| 52.
|
Kennelly, P. J.,
and Krebs, E. G.
(1991)
J. Biol. Chem.
266,
15555-15558[Free Full Text]
|
| 53.
|
Rodal, A. A.,
Tetreault, J. W.,
Lappalainen, P.,
Drubin, D. G.,
and Amberg, D. C.
(1999)
J. Cell Biol.
145,
1251-1264[Abstract/Free Full Text]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.